DollRHillAB. The mortality of doctors in relation to their smoking habits. A preliminary report. Br Med J1954; 1: 1451–1455.
2.
Bonaldi C, Pasquereau A, Hill C, et al. Hospitalizations for cardiovascular diseases attributable to tobacco smoking in France in 2015. Eur J Prev Cardiol. Epub ahead of print 19 November 2019. DOI: 10.1177/2047487319885462.
3.
PasquereauAAndlerAGuignardG, et al.le groupe Baromètre santé 2017. La consommation de tabac en France: premiers résultats du Baromètre santé 2017. Bull Epidemiol Hebd2018; 14–15: 265–273.
4.
AuneDSchlesingerSNoratT, et al.Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol2018; 25: 1437–1451.
5.
AuneDSchlesingerSNoratT, et al.Tobacco smoking and the risk of heart failure: a systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol2019; 26: 279–288.
6.
CritchleyJACapewellS. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA2003; 290: 86–97.
7.
HackshawAMorrisJKBonifaceS, et al.Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ2018; 360: j5855–j5855.
8.
SnaterseMDeckersJWLenzenMJ, et al.EUROASPIRE Investigators. Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: a registry from the European Society of Cardiology. Int J Cardiol2018; 258: 1–6.
9.
BourdillonF. 1.6 million fewer smokers in two years, unprecedented results. Bull Epidémiol Hebd2019; 15: 270–271.
10.
WirthNBéguinotEMartinetY. Tobacco control in France: what’s new?Rev Prat2019; 69: 653–657.
11.
KoppPOgrodnikM. The social cost of drugs in France in 2010. Eur J Health Econ2017; 18: 883–892.